Evidence map›Paper›PMID 26622089›Full record

ArticleMedical archives (Sarajevo, Bosnia and Herzegovina)2015

Intraocular Pressure Measurements Referring to the Corneal Thickness in Keratoconic Eyes After Corneal Crosslinking with Riboflavin and Ultraviolet A.

Sanja Sefic Kasumovic, Milka Mavija, Aida Kasumovic, Orhan Lepara, Belkisa Duric-Colic, Emir Cabric, Lejla Muhamedagic, Adisa Sakovic-Racic, Mirko Jankov

Abstract read
In one paragraph

Article in Medical archives (Sarajevo, Bosnia and Herzegovina), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sanja Sefic KasumovicEye Polyclinic "Dr. Sefic", Sarajevo, Bosnia and Herzegovina.
Milka MavijaUniversity Clinical Center, Banjaluka, Bosnia and Herzegovina.
Aida KasumovicEye Polyclinic "Dr. Sefic", Sarajevo, Bosnia and Herzegovina.
Orhan LeparaDepartment of Human Physiology, Faculty of Medicine, University of Sarajevo, Bosnia and Herzegovina.
Belkisa Duric-ColicCantonal hospital 2Dr. Irfan Ljubijankic", Bihac, Bosnia and Herzegovina.
Emir CabricPublic Health Care Institution Doboj-Jug, Matuzici, Bosnia and Herzegovina.
Lejla MuhamedagicThe Public Institution Health Centre of Sarajevo Canton, Bosnia and Herzegovina.
Adisa Sakovic-RacicEye Clinic, Clinical Center University of Sarajevo, Bosnia and Herzegovina.
Mirko JankovLaser Fokus Centre for Eye Microsurgery, Belgrade, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo determine the possible relation between intraocular pressure (IOP), central corneal thickness (CCT) and corneal resistance (CR) in kerotoconic eyes before, 3,6 and 12 months after collagen crosslinking procedure (CXL) with aim to find out does the thicker cornea means already more resistance cornea followed with higher IOP.

methodsThirty eyes (30 patients) with central keratoconus (KC)were evaluated in retrospective cross sectional study. The corneal biomechanical parameters were taken with Wave Light Allegro Oculyzer produced by Alcon before the CXL, 3, 6 and 12 months after the procedure. IOP were checked by Goldmann applanation tonometry (GAT) before, 3, 6 and 12 months after CXL.

resultsThe value of IOP before the CXL was 12,0 mmHg (10,62-15,25 mmHg), 3 months later 13,5 mmHg (11,0-16,0 mmHg), 6 months 14,0 mmHg (11,0-16,0 mmHg) and 12 months later 15,0 mmHg (10,37-17,25 mmHg) and was statistically significant higher (p=0,015) comparing to the value of IOP 3 months after the CXL, IOP 12 months after CXL procedure was statistically significant higher comparing to preoperative values (p=0,010). There were no statistically significant difference between the values 3 and 6 months after CXL. The CCT before the CXL procedure was 449 (433-505,75 microns), 3 months after CXL was 420 (383-473microns, p < 0,005), 6 months later 437 (401,25-480,25, p=0,001), 12 months after CXL 437 (401-503 microns, p=0,001). However there is statistically significant difference in CCT 12 months after CXL 437 (401-503microns p=0,032) and the value of CCT 3 months later the procedure (p=0,004) and the CCT 12 months after CXL and the value of CXL 6 months after CXL (p=0,036). The value of CCT did not show any statistically significant difference 3 and 6 months postoperatively.

conclusionAfter riboflavin-UVA CXL in eyes with KC there was significant decrease in central corneal thickness 3 and 6 months after the procedure and the thickness is almost the same 12 months later. However IOP is low before CXL, raising up 3 and 6 months after CXL but significant increase is seen 12 months later. It means the regular measurement of IOP could be the serious and confident indicator of increasing of corneal resistance which is the main goal of CXL treatment.

Indexed as

AdultCorneaCross-Linking ReagentsFemaleHumansIntraocular PressureKeratoconusMalePhotosensitizing AgentsRetrospective StudiesRiboflavinTonometry, OcularUltraviolet TherapyYoung AdultCross-Linking ReagentsPhotosensitizing AgentsRiboflavincentral corneal thicknesscollagen crosslinkingcorneal resistanceintraocular pressurekeratoconus

Identifiers

PMID26622089
PMCPMC4639345

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.